PATRICK SOON-SHIONG
CIK 1189020 · See remarks · last filed 2026-02-12
PATRICK SOON-SHIONG is a corporate insider who has filed 61 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for IBRX, was dated Feb 12, 2026. Across all open-market trades the lifetime net is +$216.7M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.07B across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.07B
9
61
$216.74M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IBRX | See remarks | 291,526,126 | $7.10 | $2.07B | $0 | 8 | 2026-02-12 |
| Heliogen, Inc. (HLGN.WS) Delisted | 10%+ Owner | 2,345,714 | $0.02 | $43.6K | $5.3K | 1 | 2023-04-17 |
| NantHealth, Inc. (NH) Delisted | Chairman and CEO | 2,899,297 | $1.35 | $3.91M | $0 | 2 | 2021-09-13 |
| ImmunityBio, Inc. (NK) Delisted | Chairman and CEO | 29,369,076 | — | — | $165.95M | 5 | 2020-06-29 |
| Tribune Publishing Co (TRNC) Delisted | Director | 8,743,619 | — | — | $52.15M | 12 | 2017-03-21 |
| SRNE | 10%+ Owner | 7,878,098 | $0.00 | $3.9K | -$1.40M | 2 | 2016-07-01 |
| Tribune Publishing Co (TPUB) Delisted | Director | 5,110,057 | — | — | $44.0K | 2 | 2016-06-13 |
| APP Pharmaceuticals, Inc. (ABII) Delisted | Director | 0 | — | — | $0 | 1 | 2008-09-15 |
| APP Pharmaceuticals, Inc. (ABBI) Delisted | Chairman and CEO | 3,286,611 | — | — | $0 | 2 | 2007-10-30 |
Recent Filings
61 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-12 | IBRX | Mixed | +777,810 | -$4.11M | EDGAR |
| 2025-02-12 | IBRX | Grant (A) | — | $0 | EDGAR |
| 2024-02-26 | IBRX | Grant (A) | — | $0 | EDGAR |
| 2023-08-30 | — | Buy (P) | +63,687,552 | $64.00M | |
| 2023-05-16 | IBRX | Buy (P) | — | $0 | EDGAR |
| 2023-04-17 | Heliogen, Inc. (HLGN.WS) Delisted | Buy (P) | +21,231 | $5.3K | EDGAR |
| 2022-11-08 | IBRX | Buy (P) | — | $0 | EDGAR |
| 2022-03-25 | IBRX | Grant (A) | — | $0 | EDGAR |
| 2021-09-13 | NantHealth, Inc. (NH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | IBRX | Grant (A) | — | $0 | EDGAR |